Success Metrics

Active Trials
3(50%)

Phase Distribution

Ph phase_1
2
33%
Ph phase_2
2
33%
Ph not_applicable
1
17%

Phase Distribution

2

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
2(40.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

6

all time

Status Distribution
Active(5)
Terminated(1)

Detailed Status

Active, not recruiting3
Not yet recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
3
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 12 (40.0%)
Phase 22 (40.0%)
N/A1 (20.0%)

Trials by Status

not_yet_recruiting233%
withdrawn117%
active_not_recruiting350%

Recent Activity

3 active trials
Showing 5 of 6
active_not_recruitingphase_2

A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above

NCT07204964
active_not_recruitingphase_2

A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older

NCT07121192
active_not_recruitingnot_applicable

Financial Incentives to Encourage Uptake of Preventive Dental Care Services Among Adults

NCT07083453
not_yet_recruitingphase_1

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study

NCT07044765
not_yet_recruitingphase_1

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults

NCT07034781
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07204964Phase 2

A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above

Active Not Recruiting
NCT07121192Phase 2

A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older

Active Not Recruiting
NCT07083453Not Applicable

Financial Incentives to Encourage Uptake of Preventive Dental Care Services Among Adults

Active Not Recruiting
NCT07044765Phase 1

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study

Not Yet Recruiting
NCT07034781Phase 1

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults

Not Yet Recruiting
NCT04799990

Study to Assess Adverse Events When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in Real World Setting

Withdrawn

All 6 trials loaded

Drug Details

Intervention Type
COMBINATION PRODUCT
Total Trials
6